title: Gastroesophageal reflux and lung disease.
abstract: Gastroesophageal reflux (GER) can cause respiratory symptoms and may trigger, drive and/or worsen airway disorders, interstitial lung diseases and lung allograft dysfunction. Whether lifestyle changes and acid suppression alone can counter and prevent the adverse effects of GER on the respiratory tract remains unclear. Recent data suggest that antireflux surgery may be more effective in preventing lung disease progression in patients with idiopathic pulmonary fibrosis or lung transplant recipients who have evidence of allograft dysfunction associated with the presence of excessive GER. Additional research and clinical trials are needed to determine the role of GER in various lung disorders and identify which interventions are most efficacious in preventing the respiratory consequences of gastroesophageal reflux disease. In addition, measuring biomarkers that indicate that gastric refluxate has been aspirated into the lower respiratory tract (e.g., pepsin and bile acid concentrations in bronchoalveolar lavage fluid) may prove helpful in both diagnosis and therapeutic decision making.
authors.affiliation: University of Wisconsin School of Medicine and Public Health, Medicine, K4/910 Clinical Science Centre, 600 Highland Avenue, Madison, WI 53792-9988, USA.
authors.forename: Keith C
authors.initials: KC
authors.lastname: Meyer
mesh_terms: D005764:Gastroesophageal Reflux / Q000150:complications* / Q000473:pathology; D006801:Humans; D008168:Lung / Q000473:pathology*; D008171:Lung Diseases / Q000209:etiology* / Q000473:pathology
keywords: gastroesophageal reflux; gastroesophageal reflux disease; lung disease; pulmonary fibrosis; respiratory aspiration